首页|自噬在心肌缺血再灌注损伤中的作用及中药干预研究进展

自噬在心肌缺血再灌注损伤中的作用及中药干预研究进展

扫码查看
急性心肌梗死(AMI)是临床常见的心血管急危重症,早期再灌注是治疗AMI最有效的举措,但血液供应的恢复可能造成心肌缺血再灌注损伤(MIRI),降低了临床获益。自噬是细胞利用溶酶体降解自身受损细胞器、异常蛋白等物质并为细胞提供能量维持内环境稳态的保护机制。近年来大量研究表明,中医药能通过多途径、多靶点有效调控细胞自噬水平,减轻氧化应激和血管内皮损伤,减少心肌细胞的凋亡,进而改善MIRI。文章基于自噬的发生、调控机制,综述了自噬及其相关通路与MIRI的关系;同时,对近年来靶向调控细胞自噬以治疗MIRI的单味中药及其有效成分和中药复方进行分类系统总结,旨为中医药在MIRI的临床治疗中提供新的思路及理论支持。
Role of Autophagy in Myocardial Ischemia-Reperfusion Injury and Research Progress on Traditional Chinese Medicine Intervention
Acute myocardial infarction(AMI)is a common cardiovascular crisis in clinical practice.Early reperfusion is the most effective treatment for AMI,but the restoration of blood supply may cause myocardial ischemia-reperfusion injury(MIRI),reducing clinical benefits.Autophagy is a protective mechanism in which cells utilize lysosomes to degrade damaged organelles,abnormal proteins,and other substances,providing energy to maintain homeostasis in the internal environment.In recent years,a large number of studies have shown that traditional Chinese medicine can effectively regulate cellular autophagy levels through multiple pathways and targets,alleviate oxidative stress and endothelial damage,reduce myocardial cell apoptosis,and thereby improve MIRI.This article reviews the relationship between autophagy and its related pathways with MIRI based on the occurrence and regulatory mechanisms of autophagy;At the same time,a systematic classification and summary of single traditional Chinese medicine,its active ingredients,and traditional Chinese medicine formulas targeting cell autophagy to treat MIRI in recent years is conducted,aiming to provide new ideas and theoretical support for the clinical treatment of MIRI with traditional Chinese medicine.

autophagymyocardial ischemia-reperfusion injurymechanism of actiontraditional Chinese medicine

余湖斌、宁博、李心平、李世淋、冯兰栓、李坪、任耀龙、赵明君

展开 >

陕西中医药大学,陕西 咸阳 712000

广西中医药大学,广西 南宁 530000

陕西中医药大学附属医院,陕西咸阳 712000

自噬 心肌缺血再灌注损伤 作用机制 中医药

2025

辽宁中医药大学学报
辽宁中医药大学

辽宁中医药大学学报

影响因子:0.775
ISSN:1673-842X
年,卷(期):2025.27(1)